#Vascular Graft market share

[market-insider]

Vascular Grafts Market Boosted By Rising Number Of Chronic Kidney Diseases, Heart Attacks And Atherosclerotic Heart Diseases

The global vascular grafts market size is anticipated to reach USD 3.1 billion by 2030 and is expected to expand at a CAGR of 7.0% during the forecast period, according to a new report by Grand View Research, Inc. The rising number of dialysis procedures and prevalence of chronic kidney diseases, heart attacks, atherosclerotic heart diseases, and stroke is boosting the adoption of vascular grafts. Moreover, the rising demand for minimally invasive surgeries among the population is impelling the market growth.

Furthermore, the increasing medical applications and developments in intraoperative techniques are driving the market. Peripheral vascular disease affects more than 200 million people worldwide. This is anticipated to raise the demand for vascular grafts during the forecast period. The outbreak of COVID-19 had a negative impact on the market growth due to the deferrals in non-essential medical procedures. It also affected the sales and operation of companies.

Gain deeper insights on the market and receive your free copy with TOC now @: Vascular Grafts Market Report

In 2021, the endovascular stent-graft products segment dominated the market with a revenue share of 63.8% due to its increasing adoption in response to the rising cases of aortic aneurysms. According to the data published by CDC, in 2019, about 9,904 deaths were witnessed due to aortic aneurysms in the United States. An unhealthy lifestyle has raised the prevalence of cardiac diseases and renal disease, thereby impelling the market growth.

Additionally, the increasing geriatric population and rising disposable income coupled with healthcare expenditure in emerging countries is contributing to market growth in these regions. The peripheral vascular grafts segment is expected to grow at the fastest rate due to increasing use in peripheral artery bypass. Also, the rising cases of hardening of arteries is boosting the demand for peripheral vascular graft.

The cardiac aneurysm application segment held the majority share in 2021 owing to the rising cases of raised blood pressure, hyperglycemia, hypercholesterolemia, etc. Also, the rising geriatric population and increasing cases of atherosclerotic heart diseases among the population are impelling the market growth. Moreover, the shifting trend toward minimally invasive treatments has raised the adoption of minimally invasive vascular implants to treat cardiac aneurysms, thereby boosting the segment growth.

On the other hand, the vascular occlusion application segment is anticipated to witness the fastest growth rate due to the increasing prevalence of vascular occlusion disease and the availability of graft procedures. Moreover, the development of novel therapies to treat vascular occlusion is anticipated to drive the market during the forecast period.

As of 2021, the polytetrafluoroethylene raw material segment held the majority share in the market and is expected to witness the fastest growth rate during the forecast period. The growth is attributed to its capability of tolerating pressures and flows in large and medium arteries; moreover, it offers low degradation and infection risk.     The key players offering innovative products that offer maximum protection and help reduce the pain is impelling the market growth. For instance, Biovic offers AVATAR PTFE Vascular Graft. It is developed using Humidity Resistant Technology and has porous microstructure on both internal and external surfaces to maximize tissue in-growth and healing response.

[stanleyhuds]

Vascular Grafts Market Size, Share, Demand, Growth, and Forecast 2025-2033

Global Vascular Grafts Industry: Key Statistics and Insights in 2025-2033

Summary:

The global vascular grafts market size reached USD 2.0 Billion in 2024.

The market is expected to reach 3.3 Billion by 2033, exhibiting a growth rate (CAGR) of 5.42% during 2025-2033.

North America leads the market, accounting for the largest vascular grafts market share.

Cardiac aneurysm exhibits a clear dominance in the market due to the rising incidence of cardiac aneurysms, necessitating vascular grafts for treatment.

Hospitals account for the majority of the market share as they are the primary healthcare facilities where vascular graft procedures are conducted.

The ongoing technological advancements in graft materials and design are supporting the market growth.

The rising shift towards minimally invasive surgeries (MIS) is propelling the market growth.

Industry Trends and Drivers:

Prevalence of Cardiovascular Diseases:

The rising global cases of cardiovascular diseases (CVDs) are boosting market growth. These diseases often need surgery that uses vascular grafts.

Technological Advancements in Graft Materials and Design:

Technological progress in graft materials and designs is boosting the market. Today's vascular grafts are biocompatible, durable, and reduce complications like infections and rejection. Innovations such as drug-eluting and tissue-engineered grafts are also emerging. These grafts aim to better integrate with the body's tissues. Such advancements improve the safety and effectiveness of vascular surgeries, thus enhancing patient outcomes.

Preference for Minimally Invasive Surgeries (MIS):

Minimally invasive surgeries (MIS) are driving market growth. Procedures like endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR) are less invasive than traditional surgeries. They also reduce hospital stays, lower infection risks, and speed up recovery. This boosts interest in specialized vascular grafts for these surgeries. Moreover, patients and doctors are leaning towards MIS for its benefits. This trend increases the demand for compatible vascular grafts.

Request for a sample copy of this report: https://www.imarcgroup.com/vascular-grafts-market/requestsample

Vascular Grafts Market Report Segmentation:

By Product:

Endovascular Stent Grafts

Hemodialysis Access Grafts

Coronary Artery By-Pass Grafts

Vascular Grafts for Aorta Disease

Peripheral Vascular Grafts

Endovascular stent grafts represent the largest segment as they are increasingly preferred for minimally invasive (MI) vascular procedures due to their efficacy and lower invasiveness.

Polytetrafluoroethylene (PTFE)

Polyester

Polyurethane

Biosynthetic

Polytetrafluoroethylene (PTFE) holds the biggest market share, attributed to its widespread use in vascular graft manufacturing, owing to its biocompatibility and durability.

By Application:

Cardiac Aneurysm

Kidney Failure

Vascular Occlusion

Coronary Artery Disease

Cardiac aneurysm exhibits a clear dominance in the market due to the rising incidence of cardiac aneurysms, necessitating vascular grafts for treatment.

By End User:

Hospitals

Ambulatory Surgical Centers (ASCs)

Hospitals account for the majority of the market share as they are the primary healthcare facilities where vascular graft procedures are conducted.

Regional Insights:

North America (United States, Canada)

Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

Latin America (Brazil, Mexico, Others)

Middle East and Africa

North America dominates the market, which can be accredited to the increasing adoption of advanced vascular graft technologies and a rising prevalence of vascular diseases in the region.

Top Vascular Grafts Market Leaders: 

Abbott Laboratories

B. Braun SE (B. Braun Holding GmbH & Co. KG)

Becton, Dickinson & Company

Cook Group Incorporated

Cordis

CryoLife Inc.

Getinge AB

Heat Medical Europe BV

LeMaitre Vascular

Medtronic plc

Terumo Corporation

W.L. Gore & Associates Inc.

Note: If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 

[health-views-updates]

Endoprosthesis Market: A Look at Emerging Opportunities

The global Endoprosthesis Market, valued at USD 10.13 billion in 2023, is set to experience substantial growth, with forecasts predicting it will reach USD 23.70 billion by 2031. This expansion is driven by a compound annual growth rate (CAGR) of 11.21% over the forecast period from 2024 to 2031. The increasing demand for advanced prosthetic devices, coupled with a rise in the aging population and higher incidence of orthopedic and cardiovascular conditions, are key factors fueling this market growth.

Endoprostheses, also known as internal prostheses, are artificial devices implanted within the body to replace or support damaged or missing biological structures. They are commonly used in joint replacements, dental implants, vascular grafts, and other surgical applications. With advancements in technology, endoprosthetic devices are becoming more durable, flexible, and efficient, providing patients with improved mobility and quality of life.

Market Dynamics and Growth Drivers

The growing prevalence of chronic conditions such as osteoarthritis, rheumatoid arthritis, and cardiovascular diseases has significantly increased the demand for endoprosthetic devices. The global aging population is a major factor contributing to the rising incidence of these conditions, as older adults are more likely to require joint replacements, hip and knee implants, and other forms of endoprostheses.

Technological advancements have also played a crucial role in driving the growth of the Endoprosthesis Market. Manufacturers are focusing on developing innovative devices that offer better compatibility, reduced wear and tear, and enhanced functionality. Additionally, the integration of 3D printing and materials like titanium and cobalt-chromium alloys has led to the production of more customized, patient-specific implants.

Get Free Sample Report@ https://www.snsinsider.com/sample-request/2625

Key Market Trends

One of the major trends in the Endoprosthesis Market is the increasing adoption of minimally invasive surgical procedures. These techniques reduce recovery time, minimize scarring, and lower the risk of complications, making them more favorable among patients and healthcare providers. The development of smaller, more adaptable endoprosthetic devices has made it possible to perform these procedures more effectively, further boosting market growth.

Another trend is the rising demand for orthopedic endoprostheses, particularly in regions with aging populations. Hip and knee replacements continue to dominate this segment, but there is also a growing market for shoulder, spinal, and extremity implants. The expanding use of vascular endoprostheses, such as stents and grafts, in treating cardiovascular conditions is also contributing to overall market expansion.

Regional Insights

North America held the largest share of the Endoprosthesis Market in 2023, driven by a well-established healthcare infrastructure, a high prevalence of chronic diseases, and robust investments in healthcare technology. The presence of leading market players and favorable reimbursement policies in the region also contribute to its market dominance.

The Asia-Pacific region is expected to exhibit the highest growth rate over the forecast period. Factors such as the rising aging population, increasing healthcare expenditure, and growing awareness of advanced medical treatments are driving market growth in countries like China, India, and Japan. Additionally, the expansion of medical tourism in the region is expected to further boost demand for endoprosthetic devices.

Key Players in the Market

The global Endoprosthesis Market is competitive, with several major players leading the market through continuous product development, strategic collaborations, and mergers & acquisitions. Key companies include Zimmer Biomet, Johnson & Johnson, Stryker Corporation, Medtronic, and Smith & Nephew. These companies are investing heavily in research and development to introduce next-generation endoprostheses that meet the evolving needs of patients and healthcare providers.

Conclusion

The Endoprosthesis Market is set to grow significantly over the coming years, driven by increasing demand for advanced prosthetic solutions, technological innovations, and the growing prevalence of chronic conditions. As healthcare providers continue to prioritize improved patient outcomes and quality of life, the demand for durable, flexible, and efficient endoprosthetic devices is expected to rise, offering substantial growth opportunities for market players.

[farmacuticals]

Competitive Landscape and Major Players in the Global Cardiovascular Prosthetic Device Market

Cardiovascular prosthetic devices are specialized medical implants designed to support or replace damaged heart valves, arteries, or other components of the cardiovascular system. These devices play a critical role in the treatment of heart-related conditions, helping improve the quality of life for patients suffering from diseases such as coronary artery disease, heart failure, and valvular heart disease. Common cardiovascular prosthetic devices include artificial heart valves, vascular grafts, stents, and pacemakers.

The Cardiovascular Prosthetic Device Market Size was projected by MRFR research to reach 67.49 (USD Billion) by 2022. It is anticipated that the market for cardiovascular prosthetic devices would increase from 70.68 billion USD in 2023 to 107.2 billion USD in 2032. Over the projected period (2024 - 2032), the Cardiovascular Prosthetic Device Market is expected to develop at a compound annual growth rate (CAGR) of about 4.73%.

The demand for cardiovascular prosthetic devices is driven by the increasing prevalence of cardiovascular diseases worldwide, attributed to factors such as aging populations, sedentary lifestyles, and unhealthy diets. These devices have significantly evolved, with advancements in biocompatible materials, minimally invasive surgical techniques, and improved long-term performance, contributing to better patient outcomes.

Cardiovascular Prosthetic Device Size

The market size for cardiovascular prosthetic devices is substantial and continues to grow at a rapid pace. In 2023, the global cardiovascular prosthetic device market was valued at several billion dollars and is projected to maintain a steady growth rate over the coming years. This growth is fueled by the rising incidence of heart diseases, increasing healthcare spending, and the adoption of advanced medical technologies.

The market is segmented into different types of cardiovascular prosthetic devices, such as heart valves, stents, pacemakers, and ventricular assist devices (VADs). Each segment has its own market size, with heart valves and stents being among the most dominant segments due to their high demand in the treatment of valve disorders and coronary artery diseases. Furthermore, the advent of minimally invasive procedures like transcatheter aortic valve replacement (TAVR) has expanded the market by offering alternatives to traditional open-heart surgery.

Cardiovascular Prosthetic Device Market Share

The cardiovascular prosthetic device market is highly competitive, with several leading companies holding significant market share. Key players include Medtronic, Abbott Laboratories, Edwards Lifesciences, and Boston Scientific. These companies are constantly investing in research and development to introduce innovative products that address unmet medical needs.

Medtronic, for instance, holds a major market share due to its wide range of cardiovascular prosthetic devices, including artificial heart valves and stents. Edwards Lifesciences is a leading player in the heart valve segment, particularly with its transcatheter heart valve products. Abbott Laboratories and Boston Scientific are also strong contenders in the stent and pacemaker markets.

Cardiovascular Prosthetic Device Trends

Several trends are shaping the cardiovascular prosthetic device market, including:

Minimally Invasive Surgeries: There is a growing preference for minimally invasive procedures such as TAVR and transcatheter mitral valve replacement (TMVR), which reduce recovery times and surgical risks for patients.

Biodegradable Stents: The development of bioresorbable stents is revolutionizing coronary artery treatment. These stents dissolve naturally after performing their function, reducing the risk of long-term complications.

Smart Implants: Technological advancements are driving the creation of smart cardiovascular prosthetic devices, such as pacemakers with remote monitoring capabilities, allowing real-time tracking of patient health.

Aging Population: With the aging global population, the demand for cardiovascular prosthetic devices is expected to increase, as elderly individuals are more prone to heart diseases.

Emerging Markets: The cardiovascular prosthetic device market is experiencing growth in emerging economies due to improving healthcare infrastructure, increased awareness, and rising healthcare spending.

Reasons to Buy the Reports

In-Depth Market Analysis: A comprehensive understanding of the current cardiovascular prosthetic device market size, share, and growth trends.

Competitive Landscape: Insights into key players, their market strategies, and the latest product innovations.

Future Market Projections: Detailed forecasts of the market growth and the factors influencing this expansion.

Technological Advancements: Information on the latest technological developments in cardiovascular prosthetic devices and how they are improving patient outcomes.

Regulatory Insights: Key regulatory guidelines and approvals that influence the cardiovascular prosthetic device market, ensuring compliance and market access.

Recent Developments in Cardiovascular Prosthetic Devices

Recent developments in the cardiovascular prosthetic device market include the introduction of next-generation transcatheter valves, bioresorbable stents, and advanced pacemakers with enhanced battery life and wireless connectivity. Moreover, collaborations between medical device companies and research institutions are leading to innovations in the design and functionality of prosthetic devices, focusing on improving patient safety and treatment efficacy. These advancements are expected to drive the growth of the cardiovascular prosthetic device market in the coming years.

Related Report:

Medical Clothing Market

Medical Kiosk Market

Molecular Quality Control Market

[credenceresearchdotblog]

The Vascular Grafts Market is projected to grow from USD 1,263.48 million in 2023 to an estimated USD 2,422.39 million by 2032, with a compound annual growth rate (CAGR) of 7.50% from 2024 to 2032. The global vascular grafts market has seen significant growth in recent years, driven by the increasing prevalence of cardiovascular diseases, the aging population, and advancements in medical technology. Vascular grafts are used in surgical procedures to bypass, repair, or replace damaged blood vessels, making them a crucial component in the treatment of various vascular conditions. These grafts can be synthetic, biological, or composite, depending on the material used, and they play a critical role in procedures such as coronary artery bypass surgery, peripheral artery disease treatment, and hemodialysis access.

Browse the full report at https://www.credenceresearch.com/report/vascular-grafts-market

Market Overview

As of 2024, the vascular grafts market is experiencing a robust growth trajectory, with a market value that is expected to reach billions of dollars in the coming years. The demand for vascular grafts is fueled by the increasing burden of cardiovascular diseases, which are among the leading causes of death globally. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) claim over 17 million lives annually, and this number is expected to rise due to factors such as unhealthy lifestyles, rising obesity rates, and an aging population.

The market is segmented based on product type, application, and end-user. The main types of vascular grafts include:

1. Endovascular Stent Grafts – Used in minimally invasive procedures to treat aneurysms or occluded blood vessels. 2. Peripheral Vascular Grafts – Typically used to bypass or replace damaged vessels in the peripheral arterial system. 3. Hemodialysis Access Grafts – Commonly used to create arteriovenous (AV) fistulas for patients undergoing dialysis.

Key Drivers of Market Growth

1. Rising Prevalence of Cardiovascular Diseases The increasing incidence of cardiovascular diseases, including coronary artery disease and peripheral artery disease, is the primary driver of the vascular grafts market. As lifestyles become more sedentary, coupled with poor dietary habits and rising levels of obesity, the demand for cardiovascular procedures such as coronary artery bypass grafting (CABG) is rising.

2. Aging Population The global population is aging, and older adults are more prone to cardiovascular diseases, atherosclerosis, and related complications. This demographic trend is a major factor contributing to the growth of the vascular grafts market. Elderly individuals often require vascular grafts in procedures such as aneurysm repair or dialysis access creation, which boosts demand.

3. Technological Advancements The development of new materials and technologies for vascular grafts has significantly enhanced their performance and outcomes. For instance, the introduction of bioengineered grafts and hybrid materials that combine synthetic and biological properties has improved the compatibility and durability of grafts. Furthermore, advancements in endovascular procedures, which are less invasive than traditional open surgeries, have driven the adoption of vascular grafts, particularly stent grafts.

4. Increasing Incidence of End-Stage Renal Disease (ESRD) The rising prevalence of diabetes and hypertension has contributed to a growing number of patients with end-stage renal disease (ESRD). These patients require hemodialysis, and vascular grafts are often used to create AV fistulas for dialysis access. As the incidence of ESRD increases, so does the demand for vascular grafts, particularly in the healthcare sector of developed countries.

Challenges Facing the Market

Despite the promising growth, the vascular grafts market faces several challenges. One major concern is the risk of graft failure due to infection, thrombosis, or rejection. While advances in material science have improved the performance of grafts, complications still arise, particularly in high-risk patients. Additionally, the cost of vascular grafts and associated procedures can be prohibitive for patients in low- and middle-income countries, limiting access to these life-saving interventions.

Another challenge is the stringent regulatory environment that governs the approval and commercialization of vascular grafts. Medical devices, especially those used in critical procedures, are subject to rigorous testing and approval processes. This can delay the introduction of new products to the market.

Regional Insights

The vascular grafts market is segmented by region, with North America, Europe, Asia-Pacific, and the Rest of the World (RoW) being key markets. North America holds the largest share of the market, driven by the high prevalence of cardiovascular diseases, a well-established healthcare system, and the presence of leading medical device manufacturers. Europe follows closely behind, with a similar disease burden and strong healthcare infrastructure.

In contrast, the Asia-Pacific region is expected to witness the fastest growth in the coming years, driven by the increasing healthcare expenditure, a growing middle class, and rising awareness of cardiovascular health. Countries such as China and India are seeing a surge in demand for vascular grafts due to the rising incidence of lifestyle-related diseases and improvements in healthcare accessibility.

Future Outlook

The future of the vascular grafts market looks promising, with continued growth expected due to ongoing advancements in medical technology, an aging population, and the increasing prevalence of cardiovascular diseases. Innovations in graft materials, such as the use of bioresorbable polymers and tissue-engineered grafts, will likely enhance the durability and success rates of vascular procedures.

Moreover, as healthcare systems in emerging economies improve, the demand for vascular grafts in these regions is expected to increase. Government initiatives aimed at improving cardiovascular health and expanding access to healthcare services will also play a crucial role in driving market growth.

Key players

Medtronic

Terumo Corporation

LeMaitre Vascular, Inc.

Getinge AB

BD (Becton Dickinson)

Abbott

Braun Melsungen AG

L. Gore and Associates, Inc.

MicroPort Scientific Corporation

Endologix

Segments

Based on product

Haemodialysis Access Grafts

Endovascular Stent Grafts

Coronary Artery Based on-Pass Grafts

Vascular Grafts for Aorta Disease

Peripheral Vascular Grafts

Based on application

Cardiac Aneurysm

Endovascular Stent Graft

Vascular Graft

Kidney Failure

Vascular Occlusion

Coronary Artery Disease

Others

Based on raw material

Synthetic Vascular Grafts

Polytetrafluoroethylene (PTFE) Grafts

Polyester Grafts,

Polyurethane Grafts

Biological Vascular Grafts

Autografts

Allografts

Xenografts

Hybrid Vascular Grafts

Based on region

North America

U.S.

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of the Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/vascular-grafts-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[nidhi0]

Artificial Blood Vessels Market: CAGR of 6.04% by 2032

As per Inkwood Research, the Global Artificial Blood Vessels Market is expected to grow at a CAGR of 6.04% in terms of revenue over the forecasting period of 2024-2032.

Artificial blood vessels are engineered substitutes designed to replace damaged or diseased vessels. They offer a solution for patients requiring vascular repair or replacement, potentially improving outcomes in procedures like bypass surgeries. Advances in materials and manufacturing techniques continue to enhance the performance and longevity of these vital medical devices.

REQUEST FREE SAMPLE  : https://inkwoodresearch.com/reports/global-artificial-blood-vessels-market/#request-free-sample

Tissue Engineering Advances to Boost Artificial Blood Vessels Market Growth

Advances in tissue engineering are significantly boosting the artificial blood vessels market by enhancing the design and functionality of these critical medical devices. Innovations in biomaterials, 3D printing, and cellular therapies are improving the durability, biocompatibility, and performance of artificial blood vessels. Researchers are developing more sophisticated scaffolding techniques and incorporating stem cell technology to create vessels that better mimic natural tissues. These advancements are addressing key challenges such as graft failure and limited availability, thereby driving market growth. As technology progresses, the artificial blood vessels market is expected to expand, offering improved solutions for vascular repair and replacement.

Large is Expected to be Prominent Blood Vessel Diameter

Large artificial blood vessel grafts, with diameters ranging from 6 mm to over 30 mm, are designed to replace or bypass major vessels like the aorta, iliac arteries, or femoral arteries. Engineered to withstand the high pressures and flow rates of the cardiovascular system, these grafts are essential in procedures such as aortic aneurysm repair, where a synthetic graft replaces a section of the aorta. Choosing the right graft material and design involves considering factors such as the vessel’s location and diameter, expected blood flow rates and pressures, and individual patient characteristics to ensure optimal performance and compatibility.

Asia-Pacific is Projected to be the Leading Region over the Forecasted Years

The Asia-Pacific has experienced significant growth in the global artificial blood vessels market, primarily due to the rising prevalence of cardiovascular diseases. The demand for vascular grafts and related procedures has surged, driven by the region's aging populations, particularly in countries like Japan and China, where elderly individuals often require vascular interventions.

The global artificial blood vessels market is highly competitive, with numerous companies vying for market share through innovation and advanced technology. Key players differentiate themselves by developing superior materials and improving graft performance to address various clinical needs and preferences. Some of the leading companies operating in the market include B Braun Melsungen AG, Becton Dickinson and Company, LeMaitre Vascular Inc, Medtronic plc, etc.

Request for Customization  : https://inkwoodresearch.com/request-for-custom-report/

Related Reports:

CHROMATOGRAPHY RESIN MARKET : https://www.inkwoodresearch.com/reports/chromatography-resin-market/ SINGLE-USE BIOPROCESSING MARKET : https://www.inkwoodresearch.com/reports/single-use-bioprocessing-market/ BONE GRAFT AND SUBSTITUTE MARKET : https://www.inkwoodresearch.com/reports/bone-graft-and-substitutes-market/

About Inkwood Research

Inkwood Research specializes in syndicated & customized research reports and consulting services. Market intelligence studies with relevant fact-based research are customized across industry verticals such as technology, automotive, chemicals, materials, healthcare, and energy, with an objective comprehension that acknowledges the business environments. Our geographical analysis comprises North & South America, CEE, CIS, the Middle East, Europe, Asia, and Africa.

Contact Us

sales@inkwoodresearch.com

1-(857)293-0150

[businessresearchreportss]

Key Players and Manufacturers in the Vascular Grafts Market: Leading Companies and Market Share Analysis

The vascular grafts market is comprised of several key players and manufacturers, with a few leading companies dominating the market.

Buy the Full Report for More Insights into the Vascular Grafts Market Forecast

Download a Free Sample Report

Here are some of the prominent players and their market share analysis:

Medtronic plc:

Medtronic is a global leader in medical technology, offering a wide range of vascular products, including vascular grafts.

The company's vascular graft portfolio includes both synthetic and biological grafts used in vascular surgery.

Medtronic holds a significant market share in the vascular grafts market, owing to its extensive product offerings and global presence.

Terumo Corporation:

Terumo Corporation is a Japanese multinational company that manufactures medical devices and equipment, including vascular grafts.

The company offers a range of vascular graft products for various applications, such as hemodialysis access and peripheral vascular surgery.

Terumo Corporation holds a considerable market share, particularly in Asia-Pacific regions.

Getinge AB:

Getinge AB, headquartered in Sweden, is a leading global provider of medical technology products and solutions, including vascular grafts.

The company's vascular graft portfolio includes synthetic grafts for vascular reconstructions and bypass surgeries.

Getinge AB has a significant presence in the European vascular grafts market and holds a notable market share in the industry.

B. Braun Melsungen AG:

B. Braun is a German medical and pharmaceutical company that manufactures a wide range of healthcare products, including vascular grafts.

The company offers vascular graft solutions for cardiovascular and peripheral vascular surgeries, catering to both synthetic and biological graft requirements.

B. Braun holds a considerable market share, particularly in Europe and other regions where its products are distributed.

LeMaitre Vascular, Inc.:

LeMaitre Vascular is a leading global provider of devices for the treatment of peripheral vascular diseases.

The company offers a diverse portfolio of vascular grafts, including prosthetic and biological grafts, used in peripheral vascular procedures.

While smaller compared to some other players, LeMaitre Vascular has been gaining market share steadily, particularly in the peripheral vascular segment.

Cook Medical Inc.:

Cook Medical is a privately held medical device company headquartered in the United States, specializing in minimally invasive medical technologies.

The company manufactures vascular grafts, including synthetic grafts for vascular access and reconstruction procedures.

Cook Medical holds a notable market share in the vascular grafts market, particularly in North America.

Market share analysis for these companies can vary by region and product segment within the vascular grafts market. However, these players are among the leading manufacturers in the industry, each contributing significantly to the market's overall growth and development.

[neha24blog]

Hemodialysis Vascular Grafts Market Scope By Raw Material, Region And Forecast To 2030: Grand View Research Inc.

San Francisco, 1 April 2024: The Report Hemodialysis Vascular Grafts Market Size, Share & Trends Analysis Report By Raw Material (Polyester, Polyurethane, Polyurethane, Biological Materials), By Region (North America, Europe, APAC), And Segment Forecasts, 2024 – 2030 The global hemodialysis vascular grafts market is expected to reach USD 296.15 million by 2030, and is anticipated to register a…

[healthcareruhi]

Vascular Guidewires Market Analysis, Share, Growth rate and Market Forecasts to 2030

The Global Vascular Guidewires Market was valued at US$ 981 Mn in 2022, estimated to reach US$ 1,791 Mn by 2030, with a CAGR of 7.69% from 2023-2030. A guidewire is a flexible wire that, in some circumstances, may also be a spring. It aids surgeons in the introduction and accurate positioning of a medical device, notably a prosthesis, within a patient's body. During an interventional procedure, the use of guidewires is crucial since they help a doctor and direct a medical instrument through the patient's anatomy. 

A guidewire completes the role of a guide towards the insertion of larger devices, such as a catheter, into the patient's body. The material majorly used in making guidewire is core steel with a covering applied over the core steel. The coating may be of hydrophilic or hydrophobic polymer. The vascular guidewires are used for the numerous surgical procedures such as angioplasty stents, angioplasty balloons, endovascular aneurysm repair stent grafts, hemodynamic flow alteration devices, and others.

Market Segmentation The scope of the Global Vascular Guidewires Market covers segmentation based on Application, Coating Type, End User, and Region. Based on Application, the market is segmented into Coronary Guidewires, Peripheral Guidewires, Urology Guidewires, and Neurovascular Guidewires. Based on Coating Type, the market is divided into Coated and Non-Coated. Based on End Users, the market is classified into Hospitals and Ambulatory Surgical Centers. Request A Free Sample@

Regional Analysis The Global Vascular Guidewires Market is segmented into 5 main regions, namely North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Key Players Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Company (C.R. Bard), Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health, Inc., Cook Medical Inc., Olympus Corporation, and Terumo Corporation.

Key Questions Addressed by the Report • What are the Key Opportunities in Global Bonsai Market?   • What will be the growth rate from 2023 to 2030?   • Which segment/region will have the highest growth?   • What are the factors that will impact/drive the Market?   • What is the competitive Landscape in the Industry?

About Us:

QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers.

QualiKet Research is dedicated to enhancing the ability of faster decision making by providing timely and scalable intelligence.

QualiKet Research strive hard to simplify strategic decisions enabling you to make right choice. We use different intelligence tools to come up with evidence that showcases the threats and opportunities which helps our clients outperform their competition. Our experts provide deep insights which is not available publicly that enables you to take bold steps.

Contact Us:

     6060 N Central Expy #500 TX 75204, U.S.A

     sales@qualiketresearch.com

     +1 214 660 5449

     1201, City Avenue, Shankar Kalat Nagar,

     Wakad, Pune 411057, Maharashtra, India

     sales@qualiketresearch.com

     +91 9284752585

     Sharjah Media City , Al Messaned, Sharjah, UAE.

     sales@qualiketresearch.com

     +91 9284752585

[vishalimarc]

The global vascular grafts market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032. The increasing number of fatal road accidents and trauma cases, rising inclination towards medical tourism, and the growing number of surgical procedures, especially among the geriatric population, are some of the major factors propelling the market.